← All stocks

Clene Inc.

CLNN Net buying

CIK 0001822791 #4669 in the set updated 19 Sep 2026

Bought (120 mo)

$21.95M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$7.11M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$7.11M

83 of 83 sales

Net

+$14.84M

+$14.84M against sales at will

By person

11 insiders · 136 transactions

1.0×

Robert Etherington holds only 1.0 times base salary in stock. $510.13K of shares against $508.76K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert Etherington last reported holding, valued at $6.20, the price Common Stock was last bought or sold at on the open market here, on 12 May 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

MATLIN DAVID J

Director

$9.87M (29)

—

+$9.87M

1,069,775

$6.63M

—

Mosca Alison

Director

$3.23M (4)

—

+$3.23M

984,474

$6.10M

—

Ugwumba Chidozie

10% owner

$7.00M (2)

$5.78M (62)

+$1.22M

103,417

$641.19K

—

General Resonance LLC entity

10% owner

—

$1.16M (18)

−$1.16M

704,591

$4.37M

−40.7%

Gay Jonathon

Director

$1.11M (3)

—

+$1.11M

1,339,119

$8.30M

+501.5%

Stevens John Henry

Director

$586.66K (3)

—

+$586.66K

908,857

$5.63M

+736.5%

Mortenson Mark

Chief Science Officer

$97.43K (1)

$50.01K (1)

+$47.42K

28,949

$179.48K

—

Etherington Robert Dee

President & CEO

$67.75K (2)

$110.84K (1)

−$43.09K

82,279

$510.13K

—

Glanzman Robert

Chief Medical Officer

—

$9.58K (1)

−$9.58K

10,564

$65.50K

—

WILCOX REED N

Director

—

575,145

$3.57M

+2,857%

Jacobovitz Shalom

Director

—

54,207

$336.08K

+62.4%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 315

Amendments (4/A) skipped 11

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 83

Transactions with no price 0

Shares from compensation/vesting 6,971,284

Sales filed before the plan box existed 6

History held since 3 Feb 2021